Investing

Anthropic shares drop after market debut, deepening worries over artificial intelligence valuations

Originally reported by ET Markets as: Anthropic's post-debut stumble delivers reality check for AI trade

22 Nov 2026, 9:00 am IST · Xecute.finance News Desk

The crisp read

Anthropic shares fell approximately 9 percent following their market debut, intensifying investor concerns regarding stretched artificial intelligence valuations and dampening sector enthusiasm. Market participants are now questioning whether the company can justify its valuation of roughly 40 times sales. Attention also centers on whether an anticipated OpenAI initial public offering next year can revive interest in artificial intelligence stocks.

Deep dive – the full story

The focus is now shifting to whether Anthropic can justify its roughly 40-times-sales valuation and whether a potential OpenAI initial public offering next year can restore appetite for AI stocks. This performance reflects broader market skepticism about astronomical revenue multiples in high-growth technology segments. Market valuations in the artificial intelligence sector depend heavily on projected future enterprise growth rather than current earnings, creating high vulnerability to macroeconomic shifts.

Previously, AI sector listings attracted unconditional buying support; the new reality shows investors demanding concrete financial performance over narrative-driven growth. Market participants are reassessing risk parameters across all high-multiple technology equities. Investors and analysts should monitor upcoming technology public offerings, evaluate portfolio exposure to high-multiple AI assets, and track revenue growth metrics against current valuations.

Watch for quarterly earnings reports from sector leaders for demand signals. Bottom line: sober market pricing requires careful stock selection rather than broad sector allocation.

Source: economictimes.indiatimes.com

This is news/educational content, not investment advice. Xecute.finance is not SEBI-registered. Consult a qualified professional before acting.

More from the Xecute news desk

Reading the static edition.

The live app adds Ask Xecute, deadline trackers, the daily quiz and one-tap deep dives.

Open this story in the Xecute app →